2022

  1. Infliximab IV to SC in IBD

  2. Adalimumab eow vs ew in CD

  3. Etrolizumab vs adalimumab in UC

  4. Adalimumab eow vs ew in UC

  5. Vedolizumab in paediatric IBD

  6. Ustekinumab in CD. Treat to target or standard of care

  7. Etrolizumab for maintenance of remission in UC

  8. Lyophilised oral microbiota transplantation for UC

  9. Ustekinumab vs adalimumab in CD